• Facebook Social Icon
  • Twitter Social Icon
  • bitcointalk-1
  • YouTube Icona sociale
  • 200px-Telegram_logo.svg
  • GiftHub
  • iconfinder_ebay_512

"Given the importance and novelty of our AIDS cure research, the news of the publication of our pioneering pilot study exploring SupT1 cell infusion therapy for HIV in humanized mice has been reported by more than 230 international news outlets such as Yahoo! Finance, Reuters, Bloomberg, MarketWatch, Boston Globe, Seeking Alpha, Wichita Business Journal, Milwaukee Journal Sentinel, News9.com, Wall Street Online Germany, and Medical News Today among many others, resulting in the study ranking among the top 5% of all research outputs tracked by Altmetric"



Innovative Bioresearch Ltd is a privately held biotech company founded by Italian research scientist Jonathan Fior with the goal of bringing innovation to the field of HIV, cancer and regeneration research. The INNBC token was issued to support our biomedical research and to be used as a means of payment to access our medical products and services. As such, INNBC is the first token to decentralize biomedical research, from the funding aspect of the research, to data sharing, using blockchain technology to decentralize biomedical data.  For achieving this goal, we developed a novel DApp that does allow you to reconrd text, images, even audio and video on the blockchain. 



First off, let's talk about what are some specific features of blockchain technology that are very useful for biomedical research:

Immutability. Scientific data need to be immutable. Once a study is peer reviewed and published, its data must be permanently stored and never altered. In the blockchain, all data is stored in every single node, never ceasing to exist, and always staying on the blockchain. It is immutability that gives the blockchain its openness and BFT (Byzantine Fault Tolerance).

Decentralization. The blockchain is designed to be distributed and synchronized across networks, making data freely available to anyone. We believe that scientific data should be shared and not being hidden behind a firewall.

Security. The kind of transactions that can be performed are strictly defined in advance and stored in the blockchain as “smart contracts”; this prevents fraudulent data from being added to the blockchain thus ensuring integrity of the database. By contrast, it would be much easier to compromise a centralized database.

Proof of Authorship. Say you make an important discovery and want an undeniable proof that you are the person who made the discovery. If you want to defend your work and claim in court to be the author, you must be able to prove it. This evidence can be difficult to provide. However, if you record the data to the blockchain with information such as a detailed description of your work, along with the name of the author, the timestamp can then prove that the data was generated at a certain point in time and has not been changed since. Such data recorded on the blockchain can legally represent an unambiguous reference to the author. 

One of the most important features of the DApp is that all the data is stored 100% on chain! That is, a true decentralized storage solution. Scientific publications include text and images, but they could also include audio, video and other file formats. This is why we needed a solution capable of storing any data on chain. This is possible if the data is stored smartly and trying to make file size as smaller as possible.


What this means is that our Dapp really has an incredibly wide range of applications in many different fields in addition to science. Below just a few examples;


•Application for Commercial Activities


Timestamping will allow you to record any relevant event for your business. Say for instance that you sold a product to a customer; you can record the event to the blockchain and include the tx as a QR code on the product itself as a proof of product authenticity and to keep track of the item.


•Application for Entertainment, Art and Software Development industries.


Identity and Timestamping will protect the intellectual property of your work, providing you with proof of authorship. This is important for a large number of fields. For instance, it would work perfectly well for NFTs where you could store your digital images on chain adding author information, instead than being stored on a centralized server as it currently happens. You could store a lower resolution version of the image or you could store it in different chunks in case of very large images.


•Application for Decentralized Messaging, News Releases, and Social Networking


Decentralization and Immutability provide a censorship resistant environment for posting content unlike traditional centralized platforms that can be controlled by the issuer (e.g., Twitter, Facebook) limiting your access to the platform, whereas this control does not exist in a decentralized platform.


We build this application on Binance Smart Chain initially due to lower gas fees, and we plant to launch an Etherum version as well once ETH 2.0 or better scaling solutions are adopted.


Now, why don't you try it yourself?


You can click here to launch the Dapp!


All you need is a brower with Metamask installed and some balance in BNB to pay for the transaction.


INNBC, InnovativeBioresearchCoin (0xEb70bbf15Fd1c0542896A80f2aF90C8FD40a9ec5) is the original and main token issued by Innovative Bioresearch for developing our novel AIDS cure research. INNBCL, InnovativeBioresearchClassic (0x0Cc9FCCFF81252F4bd8C5c6b359B14ae2Ed851cf) is a sister coin we issued at a later time for further supporting our research so we could also start cancer/regeneration research projects. Holding INNBCL makes you elegible for INNBC airdrop and bonuses, just like when we recently listed INNBC on top exchange BigOne, and INNBCL token holders were rewarded by INNBC bonuses.

INNBC ERC20 is the main asset and market for INNBC, and the best platform to buy and trade INNBC is currently the BigOne exchange (https://big.one/en/trade/INNBC-USDT).




We recently expanded to Binance Smart Chain issuing INNBC BEP20 with a gold logo (0xdf1f0026374d4bcc490be5e316963cf6df2fff19). As you can guess, we strongly believe in Binance Blockchain technology and decided to use this powerful tool to develop our next generation of DApps (decentralized applications) for scientific research to take advantage of the low fees until ETH 2.0 is released. INNBC BEP20 is a secondary and more experimental market with respect to the main ERC20 INNBC asset. Holding ERC20 INNBC will make you elegible for receiving BEP20 airdrops.



At its core, INNBC is meant to be used as a means of payment to access our medical products. As such, by owning INNBC you own access to such products, with a token backed by actual pharmaceuticals. INNBC is also the governance token for our DeFiScience ecosystem. As we aim to lauch a DAO for biomedical research projects, INNBC will also be used for voting the most promising research projects to be supported with the token. 


INNBC is also accepted as a means of payment to access discounts and services by our commercial partners. For example, we launched a partnership with the French electronic giant ARCHOS, where vouchers are given at discount for purchases to INNBC token holders. And we are working closely with many business in Italy and worldwide to accept INNBC as a means of payment. 






1. What is the difference between INNBC ERC20 and BEP20? Which asset is the main market? From which exchange should I buy INNBC? 

INNBC ERC20 is the main asset for the project and thus represents our main market. INNBC BEP20 is a more developing, experimental and thus recondary market where we are testing some defi features. So the choice is your but the ERC20 token is the main asset. At present, the best platform to buy and trade INNBC is BigOne exchange (https://big.one/en/trade/INNBC-USDT). BigOne is the most liquid market for INNBC, and on top of that BigOne is also supporting many more countries than other exchanges. As such, we suggest BigOne as the best trading platform for INNBC. We also suggest our users to use BigOne to save considerably on gas fees. In fact, you can deposit many low fees cryptocurrencies on BigOne to buy INNBC (TRC20 USDT, XRP, Dash) and then you can also hold INNBC on BigOne wallet comfortably as it is a very safe exchange. 

2. What is the difference between INNBC and INNBCL? 


INNBC (InnovativeBioresearchCoin) is the original and main token issued by Innovative Bioresearch for developing our novel AIDS cure research. INNBCL (InnovativeBioresearchClassic) is a sister coin we issued at a later time after a fork requested by our community. While INNBC is a low supply high value and more stable kind of coin used as a means of payment, some users wanted a larger supply lower price and more volatile/speculative asset, and we listened to the community and issued INNBCL. INNBCL quickly became very popular among traders.Now, we research scientists love to study many different things, including the market. There are different kind of users in crypto, wanting different kind of products. Just like Samsung issue different TV models, high-end expensive ones for those wanting the highest specs, and cheaper models for those who want the least expensive option, we also issued different tokens to provide the most complete offering for our users.INNBCL also contributes providing further funds to our research so we can also work on our cancer and COVID research projects in addition to AIDS, and the dual token system allows us to create some very interesting synergies. For example, holding INNBCL makes you eligible for INNBC airdrop and bonuses, just like when we recently listed INNBC on top exchange BigOne, and INNBCL token holders were rewarded by INNBC bonuses. The opposite is also true. We recently held an INNBCL airdrop contest where top INNBC traders would be rewarded with INNBCL.The main difference is in the utility. While both INNBC and INNBCL are accepted by us to access our biotech products, currently only INNBC is accepted as a means of payment for the other products including those offered by our commercial partners, as it is a less volatile asset.

3. What is the concept behind Innovative Bioresearch? How did this come into being?

Innovative Bioresearch Ltd is a biotech company founded by Italian research scientist Jonathan Fior with the goal of bringing innovation to the field of HIV, cancer and regeneration research. Notably, we are developing “SupT1 cell infusion therapy”, a cell-based HIV treatment estimated to be a lot cheaper than conventional antiretroviral therapy (ART) and than any gene therapy offered by other competitors.

The treatment is based on the groundbreaking HIV cure research performed by Dr. Jonathan Fior (Fior J. SupT1 Cell Infusion as a Possible Cell-Based Therapy for HIV: Results from a Pilot Study in Hu-PBMC BRGS Mice. Vaccines. 2016;4:13  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931630/)

There were 36.7million people infected by HIV globally in 2016, 17.5million of which were left untreated, according to UNAIDS. Our mission is to develop a low cost cell-based therapy solution for HIV to allow access to the treatment for those individuals who are normally left untreated due to social and/or economic limitations. We believe that this is exactly what the blockchain should be about, having the collectivity solving a global issue with decentralization means as a cryptocurrency.

Company founder Jonathan Fior was the first scientist to believe in the potential of the blockchain for biomedical research, issuing the first real biotech token with actual scientific publications, INNBC (InnovativeBioresearchCoin), in 2018. Since then we developed a very large and healthy community that supports INNBC. Behind INNBC there are many years of hard work and investments to perform and publish the research.

Given that the ICO market in 2017 was basically killed by bubble soap projects not solving any real issue inflating the market, as research scientists we believe it is our duty to bring something as solid and concrete as scientific research into crypto so that our society can actually have a return from crypto in terms of drug development for addressing global health issues such as HIV, cancer, and recently COVID19. As such, during 2018, INNBC was issued with no ICO as a truly community-driven project supported directly by its community.

4. How does it aid medical research? What are the inefficiencies within the current biotech research organizations/systems?

First, it is revolutionary how INNBC is decentralizing funding of biomedical research, bypassing economical conflict of interests of centralized pharmaceutical companies not wanting certain cheaper therapies to be developed as they aim to make as much profit as possible off of AIDS and other diseases. Our founder, Jonathan Fior, believes that “no one should make large profits out of the misery of others”; we developed INNBC allowing the collectivity to directly support the development of such therapies. INNBC is a coin with a conscience.

Next, we developed a specific implementation of blockchain technology for biomedical research to decentralize the sharing of the data itself. 

5. What are some key use-cases of Innovative Bioresearch token or how will the proceeds be used?


At its core, INNBC is meant to be used as a means of payment to access our medical products. As such, by owning INNBC you own access to such products, with a token backed by actual pharmaceuticals. INNBC is also going to be the governance token for our DeFi ecosystem. This means it will be used for voting purposes, but also to access stuff like NFTs, gaming, and all the other DeFi products in development. 

However, as we research scientists are also very ambitious people, we also wanted INNBC to become the most widely used form of digital payment. In order to achieve mass adoption of crypto we believe that a coin must have the most common utility and real world use case people would understand; that is, to be used to buy physical goods and items.

Therefore alongside the biotech specific implementations of INNBC, we started working on more general use cases. In this regard, we launched a series of prestigious partnerships with commercial companies to use INNBC. For example, we launched a partnership with the French electronic giant ARCHOS (https://www.archos.com/corporate/press/press_releases/EN_PR_ARCHOS_Innovative_Bioresearch_20180709.pdf), where vouchers are given at discount for purchases to INNBC token holders. Next, we made agreements with local merchants in Italy to have INNBC accepted as a means of payment.

Notably, we had one of the largest construction companies in Messina, Italy, accepting INNBC to buy any material and services to build or restructuring your house (we released a youtube video on this https://youtu.be/Tqkx4a554wM).

We also believe that in order to bring crypto to the mainstream, we need recognition by big brands. Amazingly, we were able to attract the attention of car manufacturer Nissan, which featured our CEO for advertising the supercar Nissan GTR on their official social channels (https://twitter.com/InnBioresearch/status/1284975408727887880?s=20). A partnership with Nissan is therefore in the work, stay tuned for upcoming news!


6. Okay, so if you're trying to develop vaccinations, why are you looking to take the route of NFTs and Swaps, e.t.c.?

That is a good question! It's because we believe that it is important to appeal to traditional users building a strong userbase that will then also contribute to scientific development. Just by simply using our dApp, you would be actively contributing to supporting our vaccine research. Isn’t this amazing? This is something unprecedented in DeFi and crypto. We call this “DeFi science”.

7. Do you mean by people using the product they contribute to your research by fees, e.t.c.?

The liquidity that is generated by the users will also support the research. As the token direcly funds the research activity, all the profits we can have by the market making activity are devoted to supporting our vaccine research.

8. How do you see the BioTech Industry being revolutionized with Blockchain? With COVID-19’s vaccine in clinical trials, do you think it could be employed there?

We believe that decentralizing the funding of scientific research is a major revolution that INNBC and thus crypto can bring because public funding holds us back significantly in terms of scientific development. Funding is generally dictated by centralized funding institutions and governments, allowing only a limited range of research projects to be developed, leaving so many promising research projects to die.

In addition, funding by public grants is completely inadequate and can take years to be issued, while in order to quickly address health issues such as COVID19, we research scientists need to have all the necessary means to promptly start working. The blockchain technology has the power to change this. Just like it can give us freedom of money, as often mentioned by Binance CEO “Changpeng Zhao”, it can also provide us with freedom of scientific research.

The blockchain could even provide a better review system than NIH peer review system that is not perfect and has several flaws; a much better system we will work to introduce would be a decentralized network of research scientists approving the research results just like miners approve genuine transactions, and receiving a reward in INNBC tokens spendable to perform more research, so that only productive scientists and quality research would be rewarded in such a system.

With regard to the applications for COVID19 trials, the same considerations we expressed previously for HIV research apply  for COVID19 research, as well as for any research. We need a better way to access scientific data, and blockchain technology can seriously help. 

Although it is true that such an application could be implemented with a centralized system, decentralization is the only way to ensure the data is not manipulated, and all information is publicly available in a platform that can’t be influenced by the will of any particular entity or government. Decentralization is essential to hand over administrative authority from central institutions managing the data, such as governments and private entities, to the collectivity.

In fact, if the database is controlled by one single entity, be it a private entity or government, it means that such entity has total control over the database, and such control can be influenced by personal conflicts of interests. Therefore, decentralization is the only way to ensure that scientific data become public property. In addition, in terms of costs, creating an infrastructure ensuring the same level of data integrity protection of a smart contract, which is basically impossible to compromise, and most importantly, maintaining such a platform up and running, would simply not be feasible.


9. Anything else you would like to add about Innovative Bioresearch or your future roadmap? The exchanges you are listed at, the technology, and the founder of the project?

We would also like to share some interesting stuff you may not know INNBC and its team. Among other things, INNBC is the main and most established coin released in Italy, and we also have an expanding local userbase. We are working closely with local commercial activities to provide all the assistance they need to use INNBC as a payment system, and our presence on the territory makes a difference in terms of trust. We have local representatives you can talk with face to face, people who will assist you and who also have their own commercial activities and understand what merchants need. Our economy was highly damaged by the COVID-19 lockdown, and many activities closed doors. Together, we are studying with the local merchants to use INNBC to jumpstart our economy and be reborn stronger than before. INNBC is not a token of the people behind a laptop, but the token for the people on the street.

Next in our roadmap is the development and expandinng of all the functionalities of InnovativeBioresearchSwap (i.e., farm, gaming, scientific Dapps ), our next generation defi exchange on Binance Smart Chain.


Now, please allow us a few words on our founder, Jonathan Fior. He dedicated his life to the quest of developing a cure for AIDS. He was born in Los Angeles, USA, 1982, to Italian parents. Jonathan’s parents moved back to Italy when he was a child, and he completed his education in Italy, a country known for its excellence in the education department.

He was always fascinated by science and completed a Bachelor of Medical Biotechnology in the University of Milan, Italy. Upon graduation he immediately started working in the field of HIV research, first in the “Luigi Sacco” University Hospital, Milan, then in the San Raffaele Scientific Institute, Milan, one of the most advanced research institution in the country.

He conceived the idea of using irradiated SupT1 cells as a decoy target for HIV-1 to prevent CD4+ T cell depletion as well as to render the virus less cytopathic. first exploring this approach in an in vitro setting in his 2012 publication. He then wanted to start in vivo animal testing. Such studies are very expensive, however. Given the lack of public funding opportunities, he decided to start his own research company founding Innovative Bioresearch in 2014 and initially started to support the research through his own private funds raised by his successful trading activity.

Interestingly, Jonathan Fior has a past as a successful stock trader and therefore a strong economy background as well, and the migration to the crypto market with his own crypto-asset felt quite natural for him. He uses to say that: “before I was investing in speculative assets, with crypto I became the speculative asset”.

But the real inspiration that made him go into crypto is the sense of a community cooperating for solving issues for the collectivity, such as supporting the development of SupT1 cell infusion therapy, our novel AIDS cure.